Nanobiotix S.A.

NASDAQ: NBTX · Real-Time Price · USD
8.14
-0.06 (-0.73%)
At close: Aug 15, 2025, 3:59 PM
8.26
1.47%
After-hours: Aug 15, 2025, 07:56 PM EDT

Nanobiotix S.A. Income Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
Revenue
-11.61M 42.2M 36.21M 5.02M 2.39M 1.33M 674K 23K
Cost of Revenue
n/a n/a n/a 754K 1.5M 1.5M 109.5K -1.07M
Gross Profit
-11.61M 42.2M 36.21M 4.26M 888K -176.5K 564.5K 1.1M
Operating Income
-68.39M -25.06M -26.78M -49.62M -50.49M -50.38M -49.8M -44.77M
Interest Income
2.63M n/a n/a 250K 1.61M 2.58M 2.78M 2.58M
Pretax Income
-68.03M -33.21M -39.58M -61.81M -61.12M -45.25M -49.49M -45.69M
Net Income
-68.13M -33.47M -39.7M -58.78M -57.04M -42.94M -47M -43.43M
Selling & General & Admin
20.06M 22.02M 22.05M 18.85M 17.48M 18.51M 19.02M 17.73M
Research & Development
40.54M 42.58M 38.4M 33.34M 31.47M 30.29M 29.23M 25.43M
Other Expenses
-3.82M 2.67M 2.54M 19K -43K -68K n/a 12K
Operating Expenses
56.78M 67.27M 62.99M 52.16M 48.99M 48.87M 48.25M 43.14M
Interest Expense
8.09M n/a n/a 3.11M 3.11M n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
56.78M 67.27M 62.99M 52.91M 50.49M 50.38M 49.81M 44.79M
Income Tax Expense
101K 261K 120K -3.03M -4.08M -2.31M -2.49M -2.26M
Shares Outstanding (Basic)
47.27M 47.12M 37.99M 35.04M 34.85M 34.84M 34.81M 34.62M
Shares Outstanding (Diluted)
47.27M 47.12M 38.82M 35.04M 34.85M 34.84M 34.81M 34.62M
EPS (Basic)
-1.44 -0.76 -1.1 -1.68 -1.64 -1.24 -1.36 -1.35
EPS (Diluted)
-1.44 -0.77 -1.11 -1.68 -1.64 -1.24 -1.36 -1.35
EBITDA
-58.32M -21.83M -23.22M -34.9M -22.35M -22.64M -22.34M -19.92M
EBIT
-59.95M -22.39M -24.24M -35.78M -22.86M -23.86M -23.58M -21.3M
Depreciation & Amortization
1.62M 561K 1.01M 1.5M 1.5M 1.5M 1.56M 1.65M